Literature DB >> 24491082

Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward?

Joao Paulo Mattos Almeida1, Rebekah A Drezek, Aaron E Foster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24491082      PMCID： PMC4025948          DOI： 10.2217/imt.13.158

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  18 in total

1.  Radiofrequency ablation for the treatment of HCC--maybe much more than simple tumor destruction?

Authors:  Tim F Greten; Firouzeh Korangy
Journal:  J Hepatol       Date:  2010-06-20       Impact factor: 25.083

2.  Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study.

Authors:  Xiaosong Li; Mark F Naylor; Henry Le; Robert E Nordquist; T Kent Teague; C Anthony Howard; Cynthia Murray; Wei R Chen
Journal:  Cancer Biol Ther       Date:  2010-12-01       Impact factor: 4.742

3.  Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity.

Authors:  Carole Bourquin; David Anz; Klaus Zwiorek; Anna-Lisa Lanz; Sebastian Fuchs; Sarah Weigel; Cornelia Wurzenberger; Philip von der Borch; Michaela Golic; Stefan Moder; Gerhard Winter; Conrad Coester; Stefan Endres
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

4.  Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine.

Authors:  Qiong Liu; Bo Zhai; Wen Yang; Le-Xing Yu; Wei Dong; Ya-Qin He; Lei Chen; Liang Tang; Yan Lin; Dan-Dan Huang; Hong-Ping Wu; Meng-Chao Wu; He-Xin Yan; Hong-Yang Wang
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

5.  In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes.

Authors:  Cristiano Sacchetti; Novella Rapini; Andrea Magrini; Elisa Cirelli; Stefano Bellucci; Maurizio Mattei; Nicola Rosato; Nunzio Bottini; Massimo Bottini
Journal:  Bioconjug Chem       Date:  2013-05-22       Impact factor: 4.774

6.  In situ tumor ablation creates an antigen source for the generation of antitumor immunity.

Authors:  Martijn H M G M den Brok; Roger P M Sutmuller; Robbert van der Voort; Erik J Bennink; Carl G Figdor; Theo J M Ruers; Gosse J Adema
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model.

Authors:  Zubing Chen; Shiqiang Shen; Baogang Peng; Jianpin Tao
Journal:  Int J Hyperthermia       Date:  2009-08       Impact factor: 3.914

8.  Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy.

Authors:  Brandon Kwong; Haipeng Liu; Darrell J Irvine
Journal:  Biomaterials       Date:  2011-04-22       Impact factor: 12.479

9.  Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice.

Authors:  Iraklis C Kourtis; Sachiko Hirosue; Alexandre de Titta; Stephan Kontos; Toon Stegmann; Jeffrey A Hubbell; Melody A Swartz
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression.

Authors:  Sofia R Gameiro; Jack P Higgins; Matthew R Dreher; David L Woods; Goutham Reddy; Bradford J Wood; Chandan Guha; James W Hodge
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240
View more
  3 in total

Review 1.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

Review 2.  Symptomatic Fibroid Management: Systematic Review of the Literature.

Authors:  Yelena Havryliuk; Robert Setton; John J Carlow; Barry D Shaktman
Journal:  JSLS       Date:  2017 Jul-Sep       Impact factor: 2.172

3.  Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort study.

Authors:  Lujun Shen; Han Qi; Shuanggang Chen; Fei Cao; Lin Xie; Ying Wu; Weimei Ma; Ze Song; Hui Yuan; Tao Zhang; Dandan Li; Xizhi Wen; Qifeng Chen; Wang Li; Xiaoshi Zhang; Weijun Fan
Journal:  Cancer Immunol Immunother       Date:  2020-04-24       Impact factor: 6.968
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.